Earnings release
Page 1
ALCIDION 25 February 2021 Australian Securities Exchange 20 Bridge Street , Sydney NSW 2000 Highlights : Alcidion H1 FY2021 Results Strong half year sales driven by strategic contract wins • H1 revenue of $ 11.1M , up 36 % on the prior corresponding period ( pcp ) • Gross profit of $ 9.8M ( 88.1 % gross profit margin ) , up from $ 7.1M ( 87.4 % ) pcp • • • • • $ 17.4M contracted revenue added in H1 , up 190 % pcp and representing one of Alcidion's highest half year sales to date Contracted revenue to be recognised in FY2021 increased to $ 21.7M , a 17 % increase on FY2020 full year revenue with further six months remaining A further $ 23.0M of sold revenue to be recognised over next five years from FY2022 to FY2026 , with $ 22.4M of that being recurring product revenue delivered at 85 % + margins Cash reserves of $ 12.5 million at 31 December 2020 Milestone contract with South Tees NHS Trust valued at $ 11.3M over five years - Melbourne , Australia – Alcidion Group Limited ( ASX : ALC ) today released its financial results for the six - month period ending 31 December 2020 ( H1 FY2021 ) . Alcidion Managing Director Kate Quirke said , “ This period was important for Alcidion . The continued uptake of our product suite and strategic headway made with key customers in our UK and ANZ markets positions us favourably for a solid second half . " The official launch of our flagship Miya Precision product suite in the UK built on our existing market presence and saw our customer base expand as we signed our largest deal to date with South Tees NHS Trust . Patientrack and Smartpage continued to open doors for new customers in the UK . " Despite the pandemic remaining a challenge for healthcare providers globally , we are still seeing a demand for investments in digital healthcare solutions , particularly in the UK where government - led investment in digital transformation remains a strategic priority . " " Our strong performance in H1 is an important validation of our investments in scaling to drive growth . As we complete our investment phase in FY2021 , we expect to see continued acceleration in revenue while our cost base stabilises , " Kate Quirke concluded . Financial Alcidion delivered revenue in H1 FY2021 of $ 11.1M , a 36 % increase on H1 FY2020 . H1 FY2021 was one of Alcidion's strongest sales performances to - date adding $ 17.4M in new sales revenue ( up 190 % pcp ) and increasing total sold revenue able to be recognised in FY2021 to $ 21.7M , 17 % higher than FY2020 full year revenue with six months of the year remaining . Of the $ 21.7M contracted to be recognised in FY2021 , $ 14.0M is recurring and $ 7.7M non - recurring . Alcidion Group Limited | Level 10 9 Yarra Street SOUTH YARRA VIC 3141 | +61 3 8060 6177 | www.alcidion.com